Equities

Modern Chinese Medicine Group Co Ltd

Modern Chinese Medicine Group Co Ltd

Actions
  • Price (HKD)0.315
  • Today's Change0.01 / 3.28%
  • Shares traded180.00k
  • 1 Year change-25.00%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments286282176
Total Receivables, Net1037871
Total Inventory464259
Prepaid expenses0.360.350.32
Other current assets, total0.340.280.26
Total current assets437402307
Property, plant & equipment, net889084
Goodwill, net------
Intangibles, net0.200.290.39
Long term investments------
Note receivable - long term------
Other long term assets------
Total assets529502396
LIABILITIES
Accounts payable313929
Accrued expenses101715
Notes payable/short-term debt000
Current portion long-term debt/capital leases0.070.390.34
Other current liabilities, total7.511715
Total current liabilities497359
Total long term debt000.07
Total debt0.070.390.41
Deferred income tax6.765.25--
Minority interest------
Other liabilities, total------
Total liabilities567959
SHAREHOLDERS EQUITY
Common stock5.015.015.01
Additional paid-in capital109109117
Retained earnings (accumulated deficit)351302214
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total8.247.081.01
Total equity473423337
Total liabilities & shareholders' equity529502396
Total common shares outstanding600600600
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.